Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults

NCT07688369 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Polio Immunity

Interventions

BIOLOGICAL: Recombinant Poliomyelitis Vaccine (rPV)
BIOLOGICAL: Inactivated Poliomyelitis Vaccine (IPOL)

Sponsor

Serum Institute of India Pvt. Ltd.